Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$0.49 USD
-0.05 (-8.53%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $0.50 +0.01 (1.42%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.04 | 0.00% |
Earnings Summary
For their last quarter, Aligos Therapeutics (ALGS) reported earnings of $0.03 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 118.75%. Look out for ALGS's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year increase of 90.24%.
Earnings History
Price & Consensus
Zacks News for ALGS
Mirum (MIRM) Rises More Than 30% in Past 3 Months: Here's Why
ALGS: What are Zacks experts saying now?
Zacks Private Portfolio Services